4D Molecular Therapeutics Interim Clinical Data from the On-going Phase 1/2 Clinical Trial of 4D-710 for Cystic Fibrosis Lung Disease to be Presented at NACFC 2022
4D Molecular Therapeutics to host a conference call on November 3rd, 4:30 pm E.T. EMERYVILLE,…
Your Next Customer Isn’t Googling You. They’re Asking AI
Rhino Propels Federated AI into the Enterprise Tech Stack